Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia

Veterinary Parasitology

Volumn 131, Issue 3-4, 2005, Pages 193-196

  Mealey, Katrina L ^a   Munyard, Kylie A ^b   Bentjen, Steven A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b MURDOCH UNIVERSITY   (Australia)

Author keywords

Australian Shepherd; Border Collie; Collie; Ivermectin; MDR1; P glycoprotein; Shetland Sheepdog

Indexed keywords

IVERMECTIN; MULTIDRUG RESISTANCE PROTEIN 1;

ALLELE; AMPLICON; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BREED; CONTROLLED STUDY; DECISION MAKING; DNA EXTRACTION; DOG; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE; HERD; HETEROZYGOSITY; HOMOZYGOSITY; MOUTH CAVITY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; THROAT CULTURE; VETERINARY MEDICINE; WILD TYPE;

ALLELES; ANIMALS; AUSTRALIA; DNA; DOGS; DRUG RESISTANCE, MULTIPLE; FRAMESHIFT MUTATION; GENES, MDR; IVERMECTIN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

CANIS FAMILIARIS;

EID: 22244452612     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2005.05.004     Document Type: Article

References (18)

1. M.F. Fromm Genetically determined differences in P-glycoprotein function: implications for disease risk Toxicology 181 2002 299 303
2. C. Hugnet, J.L. Cadore, F. Buronfosse, X. Pineau, T. Mathet, and P.J. Berny Loperamide poisoning in the dog Vet. Hum. Toxicol. 38 1996 31 33
3. J.W. Jonker, E. Wagenaar, L. van Deemter, R. Gottschlich, H.M. Bender, J. Dasenbrock, and A.H. Schinkel Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug Br. J. Pharmacol. 127 1999 43 50
4. R.B. Kim, M.F. Fromm, C. Wandel, B. Leake, A.J. Wood, D.M. Roden, and G.R. Wilkinson The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 101 1998 289 294
5. K.L. Mealey, S.A. Bentjen, J.M. Gay, and G.H. Cantor Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene Pharmacogenetics 11 2001 727 733
6. K.L. Mealey, S.A. Bentjen, and D.K. Waiting Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States Am. J. Vet. Res. 63 2002 479 481
7. K.L. Mealey, N.C. Northrup, and S.A. Bentjen Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity J. Am. Vet. Med. Assoc. 223 1453-1455 2003 1434
8. M.W. Neff, K.R. Robertson, A.K. Wong, N. Safra, K.W. Broman, M. Slatkin, K.L. Mealey, and N.C. Pedersen Breed distribution and history of canine mdr1-1{Delta}, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage Proc. Natl. Acad. Sci. U.S.A. 101 2004 11725 11730
9. A.J. Paul, W.J. Tranquilli, R.L. Seward, K.S. Todd Jr., and J.A. DiPietro Clinical observations in collies given ivermectin orally Am. J. Vet. Res. 48 1987 684 685
10. J.M. Preston Adverse reactions to unapproved applications Vet. Rec. 112 1983 286
11. B. Richards, J. Skoletsky, A.P. Shuber, R. Balfour, R.C. Stern, H.L. Dorkin, R.B. Parad, D. Witt, and K.W. Klinger Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs Hum. Mol. Genet. 2 1993 159 163
12. S.P. Rohrer, and D.V. Evans Binding characteristics of ivermectin in plasma from collie dogs Vet. Res. Commun. 14 1990 157 165
13. A. Roulet, O. Puel, S. Gesta, J.F. Lepage, M. Drag, M. Soll, M. Alvinerie, and T. Pineau MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin Eur. J. Pharmacol. 460 2003 85 91
14. L.L. Sartor, S.A. Bentjen, L. Trepanier, and K.L. Mealey Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity J. Vet. Intern. Med. 18 2004 117 118
15. A.H. Schinkel, J.J.M. Smit, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, C.A.A.M. Mol, M.A. van der Valk, E.C. Robanus-Maandag, H.P.J. te Riele, A.J.M. Berns, and P. Borst Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502 (%20)
16. R.L. Seward Reactions in dogs given ivermectin J. Am. Vet. Med. Assoc. 183 1983 493
17. W.J. Tranquilli, A.J. Paul, R.L. Seward, K.S. Todd, and J.A. DiPietro Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis J. Vet. Pharmacol. Ther. 10 1987 96 100
18. D.M. Vaughn, S.T. Simpson, B.L. Blagburn, W.L. Whitmer, R. Heddens-Mysinger, and C.M. Hendrix Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin Vet. Res. Commun. 13 1989 47 55